SK12772000A3 - 3-(5-metylizoxazol-3-yl)-6-(1-metyl-1,2,3-triazol-4-yl)metyloxy- -1,2,4-triazolo[3,4-a]ftalazín, farmaceutický prostriedok s jeho obsahom a jeho požitie - Google Patents
3-(5-metylizoxazol-3-yl)-6-(1-metyl-1,2,3-triazol-4-yl)metyloxy- -1,2,4-triazolo[3,4-a]ftalazín, farmaceutický prostriedok s jeho obsahom a jeho požitie Download PDFInfo
- Publication number
- SK12772000A3 SK12772000A3 SK1277-2000A SK12772000A SK12772000A3 SK 12772000 A3 SK12772000 A3 SK 12772000A3 SK 12772000 A SK12772000 A SK 12772000A SK 12772000 A3 SK12772000 A3 SK 12772000A3
- Authority
- SK
- Slovakia
- Prior art keywords
- triazolo
- phthalazine
- methyl
- methylisoxazol
- methyloxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9803992.8A GB9803992D0 (en) | 1998-02-25 | 1998-02-25 | Therapeutic agents |
| PCT/GB1998/001307 WO1998050385A1 (en) | 1997-05-08 | 1998-05-06 | SUBSTITUTED 1,2,4-TRIAZOLO[3,4-a]PHTHALAZINE DERIVATIVES AS GABA ALPHA 5 LIGANDS |
| GBGB9824896.6A GB9824896D0 (en) | 1998-11-12 | 1998-11-12 | Therapeutic compound |
| PCT/GB1999/000485 WO1999043677A1 (en) | 1998-02-25 | 1999-02-17 | SUBSTITUTED 1,2,4-TRIAZOLO[3,4-a]PYRIDAZINE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK12772000A3 true SK12772000A3 (sk) | 2001-03-12 |
Family
ID=27269184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1277-2000A SK12772000A3 (sk) | 1998-02-25 | 1999-02-17 | 3-(5-metylizoxazol-3-yl)-6-(1-metyl-1,2,3-triazol-4-yl)metyloxy- -1,2,4-triazolo[3,4-a]ftalazín, farmaceutický prostriedok s jeho obsahom a jeho požitie |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1070066A1 (ru) |
| JP (1) | JP2002504554A (ru) |
| CN (1) | CN1291194A (ru) |
| AU (1) | AU746719B2 (ru) |
| BG (1) | BG104705A (ru) |
| CA (1) | CA2317416A1 (ru) |
| EA (1) | EA002824B1 (ru) |
| HR (1) | HRP20000555A2 (ru) |
| HU (1) | HUP0100647A3 (ru) |
| NZ (1) | NZ505695A (ru) |
| PL (1) | PL341975A1 (ru) |
| SK (1) | SK12772000A3 (ru) |
| TR (1) | TR200002469T2 (ru) |
| WO (1) | WO1999043677A1 (ru) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9821179D0 (en) * | 1998-09-30 | 1998-11-25 | Merck Sharp & Dohme | Therapeutic use |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH21834A (en) * | 1982-01-18 | 1988-03-17 | Lepetit Spa | New 6-substituted-s-triazolo(3,4-a)phthalazine derivatives |
| WO1998004560A1 (en) * | 1996-07-25 | 1998-02-05 | Merck Sharp & Dohme Limited | SUBSTITUTED TRIAZOLO PYRIDAZINE DERIVATIVES AS INVERSE AGONISTS OF THE GABAAα5 RECEPTOR SUBTYPE |
| CA2288789C (en) * | 1997-05-08 | 2009-07-21 | Merck Sharp & Dohme Limited | Substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives as gaba alpha 5 ligands |
-
1999
- 1999-02-17 SK SK1277-2000A patent/SK12772000A3/sk unknown
- 1999-02-17 EP EP99905069A patent/EP1070066A1/en not_active Withdrawn
- 1999-02-17 CN CN99803190A patent/CN1291194A/zh active Pending
- 1999-02-17 EA EA200000878A patent/EA002824B1/ru not_active IP Right Cessation
- 1999-02-17 PL PL99341975A patent/PL341975A1/xx not_active Application Discontinuation
- 1999-02-17 WO PCT/GB1999/000485 patent/WO1999043677A1/en not_active Application Discontinuation
- 1999-02-17 AU AU25368/99A patent/AU746719B2/en not_active Ceased
- 1999-02-17 TR TR2000/02469T patent/TR200002469T2/xx unknown
- 1999-02-17 JP JP2000533432A patent/JP2002504554A/ja not_active Withdrawn
- 1999-02-17 HU HU0100647A patent/HUP0100647A3/hu unknown
- 1999-02-17 NZ NZ505695A patent/NZ505695A/en unknown
- 1999-02-17 CA CA002317416A patent/CA2317416A1/en not_active Abandoned
-
2000
- 2000-08-22 BG BG104705A patent/BG104705A/bg unknown
- 2000-08-25 HR HR20000555A patent/HRP20000555A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999043677A1 (en) | 1999-09-02 |
| CA2317416A1 (en) | 1999-09-02 |
| HUP0100647A3 (en) | 2003-03-28 |
| CN1291194A (zh) | 2001-04-11 |
| JP2002504554A (ja) | 2002-02-12 |
| AU746719B2 (en) | 2002-05-02 |
| HRP20000555A2 (en) | 2001-08-31 |
| BG104705A (bg) | 2001-04-30 |
| EA200000878A1 (ru) | 2001-02-26 |
| TR200002469T2 (tr) | 2000-12-21 |
| NZ505695A (en) | 2002-03-01 |
| EA002824B1 (ru) | 2002-10-31 |
| HUP0100647A2 (hu) | 2001-09-28 |
| AU2536899A (en) | 1999-09-15 |
| EP1070066A1 (en) | 2001-01-24 |
| PL341975A1 (en) | 2001-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6313125B1 (en) | Therapeutically active 1,2,4-triazolo[4.,3-B] pyridazine derivatives as ligands for GABA receptors | |
| CZ290883B6 (cs) | Triazolopyridazinové deriváty, způsob jejich výroby a farmaceutický prostředek je obsahující | |
| JP2000515851A (ja) | ＧＡＢＡ▲下Ａα５▼レセプターサブタイプの逆アゴニストとしての置換のあるトリアゾロピリダジン誘導体 | |
| JP2002501070A (ja) | Ｇａｂａ受容体のリガンドとしてのトリアゾロ−ピリダジン誘導体 | |
| EP1885725A1 (en) | Tricyclic azole derivatives, their manufacture and use as pharmaceutical agents | |
| CZ20004872A3 (cs) | Substituovaný triazolopyridazinový derivát | |
| JP2002501071A (ja) | Ｇａｂａ受容体のリガンドとしてのトリアゾロ−ピリダジン誘導体 | |
| US6949549B2 (en) | Imidazolophthalazine derivatives as ligands for GABAA receptors | |
| JP2002501069A (ja) | Ｇａｂａ受容体のためのリガンドとしてのトリアゾロ−ピリダジン誘導体 | |
| US6297235B1 (en) | Triazolopyridazine derivatives for treating anxiety and enhancing cognition | |
| SK12772000A3 (sk) | 3-(5-metylizoxazol-3-yl)-6-(1-metyl-1,2,3-triazol-4-yl)metyloxy- -1,2,4-triazolo[3,4-a]ftalazín, farmaceutický prostriedok s jeho obsahom a jeho požitie | |
| US6448249B1 (en) | Substituted 1,2,4-triazolo[3,4-A]phthalazine derivatives as GABAα5 ligands | |
| JP2002536449A (ja) | Ｇａｂａレセプターに対するリガンドとしてのトリアゾロ−ピリダジン誘導体 | |
| US6946461B2 (en) | Imidazolophthalazine derivatives as ligands for GABAA receptors | |
| US6613766B1 (en) | Pentaaza-cyclopental[a]naphthalene derivatives as ligands for GABAa α5 receptors | |
| US7022724B2 (en) | Cognition enhancing derivatives of isoxazole triazoloindane GABA-A α5 receptor subunit ligands | |
| CA2631034A1 (en) | Tricyclic lactam derivatives, their manufacture and use as pharmaceutical agents | |
| JP2001519350A (ja) | ナフト−イミダゾ［１，２−ａ］ピリジン誘導体、その製造及び中枢神経系障害の処置におけるその使用 | |
| MXPA00008320A (en) | SUBSTITUTED 1,2,4-TRIAZOLO[3,4-a]PYRIDAZINE | |
| HRP980584A2 (en) | SUBSTITUTED 1,2,4-TRIAZOLO/3,4-a/ PHTHALAZINE |